Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment.
about
Host factors and early treatments to restrict paediatric HIV infection and early disease progressionGetting to 90-90-90 in paediatric HIV: What is needed?Neutralization-sensitive R5-tropic simian-human immunodeficiency virus SHIV-2873Nip, which carries env isolated from an infant with a recent HIV clade C infection.Introducing a multi-site program for early diagnosis of HIV infection among HIV-exposed infants in TanzaniaPromising antibody testing strategies for early infant HIV infection diagnosis in China.Predictors for mortality and loss to follow-up among children receiving anti-retroviral therapy in Lilongwe, Malawi.Outcomes of the South African National Antiretroviral Treatment Programme for children: the IeDEA Southern Africa collaboration.Assessing the efficiency of mother-to-child HIV prevention in low- and middle-income countries using data envelopment analysis.Paediatric antiretroviral treatment programmes in sub-Saharan Africa: a review of published clinical studiesGlobal, regional, and national estimates of pneumonia burden in HIV-infected children in 2010: a meta-analysis and modelling study.Molecular mechanisms of HIV-1 mother-to-child transmission and infection in neonatal target cells.Analysis of HIV tropism in Ugandan infants.PCR pattern of HIV-exposed infants in a tertiary hospital.Temporal trends in the characteristics of children at antiretroviral therapy initiation in southern Africa: the IeDEA-SA CollaborationEarly Infant Diagnosis: A New Tool of HIV Diagnosis in Children.Effectiveness of Early Infant Diagnosis (EID) in Detecting the Serostatus of HIV-Exposed Infants and Children.Gastrointestinal and nutritional complications of human immunodeficiency virus infectionMortality and loss to programme before antiretroviral therapy among HIV-infected children eligible for treatment in The Gambia, West AfricaCD4+/CD8+ T cell ratio for diagnosis of HIV-1 infection in infants: Women and Infants Transmission Study.Obstetrical, maternal characteristics and outcome of HIV-infected rapid progressor infants at Yaounde: a retrospective studyAssociation between efavirenz-based compared with nevirapine-based antiretroviral regimens and virological failure in HIV-infected children.Evaluation of Early Infant Diagnosis of HIV 1 in Government hospital, DhuleSurvival from 9 months of age among HIV-infected and uninfected Zambian children prior to the availability of antiretroviral therapyPotential cost-effectiveness of a new infant tuberculosis vaccine in South Africa--implications for clinical trials: a decision analysis.Breast milk and in utero transmission of HIV-1 select for envelope variants with unique molecular signatures.Age and CD4 count of vertically HIV-infected children at the time of diagnosis: what are independent predictors for being symptomatic and CD4 counts drop?Mortality of HIV-infected and uninfected children in a longitudinal cohort in rural south-west Uganda during 8 years of follow-up.Targeting 90-90-90--don't leave children and adolescents behind.Adherence to antiretroviral therapy in a clinical cohort of HIV-infected children in East Africa.Research gaps in neonatal HIV-related care.Challenges and opportunities for expanding HIV care and treatment: what can be
P2860
Q28082411-29A6A35A-CD2C-4AF2-AE67-A92FADB463BEQ30385352-BF1C9BB9-DE6D-4FA6-821E-483582856EA5Q33382060-B95A9655-1D1C-4FE6-ABD3-76DB4DF490E3Q33610946-472E8B1C-E2AD-4564-AF09-90E025BB5782Q33817149-08569BCB-4204-4379-AF7E-036771863B03Q33943480-4B5DEB27-DB00-480E-A31C-624D9B51D023Q34077658-9CA0E7CC-5F1E-417D-9949-89542F0FE66EQ34165971-55D29BF1-53F1-40A8-BD20-158DFF1CBA8DQ34358076-40649ACF-02B4-4441-B0AE-C8D4129D8F02Q34563804-D1FAE77B-86DA-4B2A-BA39-E219488F132DQ34626428-BCB9E8E6-6421-41B8-9D20-94358FBD3881Q34786687-57E1C377-6463-45AF-BD0D-63C249187F62Q34808870-86A2138F-0875-4EC6-9C31-47E43CC8642FQ35074354-7DF21341-85EB-40C1-A30B-E8D1FD529001Q35234407-36CA0886-86BB-4315-BC4B-B90789487794Q36083780-743685F1-D22D-41D5-BC55-E3D5C8B2E6DAQ36233095-BC737081-46A9-4BA6-8AFB-2FEFE294D66CQ36420723-F53714EB-443D-4A04-8F53-778C43B46E12Q36425097-EF585843-5F54-4BBC-AAFB-3FD8C2E956A1Q36864869-9104DEF2-8017-40BB-9620-2C440B682558Q37108384-73E2C3FA-7922-49ED-BBA9-C03963374B21Q37258970-632D27F4-699A-4BBC-82D4-0B4BF80E643DQ37365617-2A4F1920-53D3-4E6D-8A38-E6D0E1A9D13AQ37483591-AB255A4D-4E76-4698-ABA2-1F0A87AA0106Q37607872-E3CA6516-8B4F-425B-9EBC-83437C3B3281Q37756416-209A24BD-D53F-4996-81A2-67F30EB0770FQ38867914-09715E02-9634-41A9-8AD1-57D592634624Q43142354-AF3C794D-066A-458B-B2F3-C2C8269C5792Q50025133-2D7BA299-DF90-4013-9036-D5D193B27468Q53800271-C504135B-33D9-4EF0-9502-8E5611A95070Q55546974-3A17C12D-C8E1-4A38-B7C4-6AE09C200A17
P2860
Disease progression in children with vertically-acquired HIV infection in sub-Saharan Africa: reviewing the need for HIV treatment.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Disease progression in childre ...... ng the need for HIV treatment.
@en
type
label
Disease progression in childre ...... ng the need for HIV treatment.
@en
prefLabel
Disease progression in childre ...... ng the need for HIV treatment.
@en
P2093
P50
P1433
P1476
Disease progression in childre ...... ng the need for HIV treatment.
@en
P2093
Kirsty Little
Ngashi Ngongo
Peter McDermott
P304
P356
10.2174/157016207780077002
P577
2007-03-01T00:00:00Z